Bank of America
TELO icon

Bank of America’s Telomir Pharmaceuticals TELO Stock Holding History

Bank of America’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$30 – 6973
2025
Q4 		$30 Hold
23
– – ﹤0.01% 7047
2025
Q3 		$32 Sell
23
-7,420
-100% -$11.2K ﹤0.01% 8103
2025
Q2 		$9.3K Sell
7,443
-1,621
-18% -$3.75K ﹤0.01% 7209
2025
Q1 		$29.3K Sell
9,064
-5,649
-38% -$24.7K ﹤0.01% 6870
2024
Q4 		$60.6K Buy
14,713
+10,880
+284% +$51.3K ﹤0.01% 6576
2024
Q3 		$24.6K Buy
3,833
+1,443
+60% +$7.03K ﹤0.01% 6703
2024
Q2 		$11.5K Buy
+2,390
New +$14.9K ﹤0.01% 6867

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

Bank of America's TELO Position: Q1 2026 in Review

Bank of America sold out of Telomir Pharmaceuticals (TELO) in Q1 2026, closing a stake of 23 shares — an estimated $30 sold.

Bank of America first reported a position in TELO in Q2 2024 and held it in 7 quarters. The position peaked at $60.6K in Q4 2024. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Bank of America reported no remaining Telomir Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 23 Telomir Pharmaceuticals shares in Q1 2026, an estimated $30.
  • Bank of America first reported a position in Telomir Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • Bank of America's Telomir Pharmaceuticals position peaked at $60.6K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.